Advanced search
Publication Cover
Journal of Obstetrics and Gynaecology Volume 41, 2021 - Issue 6
Submit an article Journal homepage
679
Views
10
CrossRef citations to date
0
Altmetric
Review Articles:Gynaecology

Ever-use of the intra-uterine device and the risk of ovarian cancer

Jacques BalaylaDepartment of Obstetrics and Gynecology, McGill University, Montreal, CanadaCorrespondence[email protected]
,
Yaron GilDepartment of Obstetrics and Gynecology, McGill University, Montreal, CanadaORCID Iconhttps://orcid.org/0000-0002-5272-0574
ORCID Icon,
Ariane LasryDepartment of Obstetrics and Gynecology, McGill University, Montreal, Canada
&
Cristina MitricDepartment of Obstetrics and Gynecology, McGill University, Montreal, Canada
Pages 848-853 | Published online: 12 Oct 2020

References

  • Canadian Cancer Statistics Advisory Committee. 2018. Canadian Cancer Statistics. 2018. [cited 2019 Jul 1]. Available from: cancer.ca/Canadian-Cancer-Statistics-2018-EN.
  • Chen Y, Wu PC, Lang JH, Ge WJ, Hartge P, Brinton LA. 1992. Risk factors for epithelial ovarian cancer in Beijing, China. International Journal of Epidemiology 21:23–29.
  • Cibula D, Widschwendter M, Majek O, Dusek L. 2011. Tubal ligation and the risk of ovarian cancer: review and meta-analysis. Human Reproduction Update 17:55–67.
  • Collaborative Group on Epidemiological Studies of Ovarian Cancer, Beral V, Doll R, Hermon C, Peto R, Reeves G. 2008. Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls. Lancet 371:303–314.
  • Dorjgochoo T, Shu XO, Li HL, Qian HZ, Yang G, Cai H, et al. 2009. Use of oral contraceptives, intrauterine devices and tubal sterilization and cancer risk in a large prospective study, from 1996 to 2006. International Journal of Cancer 124:2442–2449.
  • Hoffman BL, Schorge JO, Bradshaw KD, Halvorson LM, Schaffer JI, Corton MM. 2016. Williams gynecology. New York: McGraw-Hill Education.
  • Huang Z, Gao Y, Wen W, Li H, Zheng W, Shu XO, Beeghly-Fadiel A. 2015. 'Contraceptive methods and ovarian cancer risk among Chinese women: a report from the Shanghai Women's Health Study. International Journal of Cancer 137:607–614.
  • Jacobs IJ, Menon U, Ryan A, Gentry-Maharaj A, Burnell M, Kalsi JK, et al. 2016. Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial. Lancet (London, England) 387:945–956.
  • Jareid M, Thalabard JC, Aarflot M, Bovelstad HM, Lund E, Braaten T. 2018. Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer. Results from the NOWAC Study. Gynecologic Oncology 149:127–132.
  • Le DC, Kubo T, Fujino Y, Sokal DC, Vach TH, Pham TM, Matsuda S. 2012. Reproductive factors in relation to ovarian cancer: a case-control study in Northern Vietnam. Contraception 86:494–499.
  • Ness RB, Dodge RC, Edwards RP, Baker JA, Moysich KB. 2011. Contraception methods, beyond oral contraceptives and tubal ligation, and risk of ovarian cancer. Annals of Epidemiology 21:188–196.
  • Ness RB, Grisso JA, Vergona R, Klapper J, Morgan M, Wheeler JE, Health Study of, and Group Reproduction Study. 2001. Oral contraceptives, other methods of contraception, and risk reduction for ovarian cancer. Epidemiology 12:307–312.
  • Shu XO, Brinton LA, Gao YT, Yuan JM. 1989. Population-based case-control study of ovarian cancer in Shanghai. Cancer Research 49:3670–3674.
  • Siegel RL, Miller KD, Jemal A. 2019. Cancer statistics, 2019. CA: A Cancer Journal for Clinicians 69:7–34.
  • Soini T, Hurskainen R, Grenman S, Maenpaa J, Paavonen J, Pukkala E. 2014. Cancer risk in women using the levonorgestrel-releasing intrauterine system in Finland. Obstetrics and Gynecology 124:292–299.
  • Soini T, Hurskainen R, Grenman S, Maenpaa J, Paavonen J, Pukkala E. 2016. Impact of levonorgestrel-releasing intrauterine system use on the cancer risk of the ovary and fallopian tube. Acta Oncologica (Stockholm, Sweden) 55:1281–1284.
  • Tworoger SS, Fairfield KM, Colditz GA, Rosner BA, Hankinson SE. 2007. Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk. American Journal of Epidemiology 166:894–901.
  • Voutsadakis IA. 2016. Hormone receptors in serous ovarian carcinoma: prognosis, pathogenesis, and treatment considerations. Clinical Medicine Insights Oncology 10:17–25.
  • Wheeler LJ, Desanto K, Teal SB, Sheeder J, Guntupalli SR. 2019. Intrauterine device use and ovarian cancer risk: a systematic review and meta-analysis. Obstetrics and Gynecology 134:791–800.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.